RECOMMENDATION23 Even though cyclo-oxygenase (COX)-1 or COX-2 inhibitors may slow progression of gastric precancerous conditions, they cannot be recommended specifically for thispurpose.Low quality evidence, weak recommendation (100 %agree [94 % strongly or moderately agree]).